Is your firm ready to meet its new obligation to report quantities of drugs manufactured? Is your staff prepared to provide the level of detailed information necessary to be submitted? Are you overwhelmed with the thought of tackling this new requirement and submitting the information in the next 10 weeks?
Leonard Krause (of AAHP member FDA Direct) will provide the answers to two fundamental questions:
• What is required of your company?
• How do you submit the necessary information?
With the clear roadmap he provides, your company will find this undertaking less involved and complex than it looks right now.